A novel sarcoma with dual differentiation: Clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1093-1098

  Vergara Lluri, Maria E ^a   Stohr, Bradley A ^b   Puligandla, Balaram ^c   Brenholz, Pauline ^d   Horvai, Andrew E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Kaiser Oakland Hospital   (United States)

^d Integrated Genetics   (United States)

Author keywords

dual histotype; extraskeletal myxoid chondrosarcoma; gene rearrangement; synovial sarcoma

Indexed keywords

CALMODULIN BINDING PROTEIN; DNA BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; NR4A3 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; RNA BINDING PROTEIN; SS18 PROTEIN, HUMAN; STEROID RECEPTOR; SYT SSX FUSION PROTEIN; SYT-SSX FUSION PROTEIN; THYROID HORMONE RECEPTOR; TUMOR MARKER;

ADULT; ARM; ARTICLE; BONE TUMOR; CASE REPORT; CHEMISTRY; CHONDROSARCOMA; CONNECTIVE TISSUE TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MIXED TUMOR; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; ARM; BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; CHONDROSARCOMA; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, COMPLEX AND MIXED; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84863304369     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824cd174     Document Type: Article

References (33)

1. Amary MF, Berisha F, Bernardi Fdel C, et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol. 2007; 20:482-496. (Pubitemid 46482372)
2. Antonescu CR, Katabi N, Zhang L, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50:559-570.
3. Antonescu CR, Zhang L, Chang NE, et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer. 2010;49:1114-1124.
4. Bergh P, Meis-Kindblom JM, Gherlinzoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85:2596-2607. (Pubitemid 29272746)
5. Brandal P, Panagopoulos I, Bjerkehagen B, et al. Detection of a t(1;22)(q23;q12) translocation leading to an EWSR1-PBX1 fusion gene in a myoepithelioma. Genes Chromosomes Cancer. 2008;47: 558-564. (Pubitemid 351748342)
6. Codrington R, Pannell R, Forster A, et al. The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells. PLoS Biol. 2005;3:e242.
7. Coindre JM, Pelmus M, Hostein I, et al. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases. Cancer. 2003;98:2700-2707. (Pubitemid 37509536)
8. Doecke JD, Day CJ, Stephens AS, et al. Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res. 2006;21:265-273. (Pubitemid 43265292)
9. Erkizan HV, Uversky VN, Toretsky JA. Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clin Cancer Res. 2010;16:4077-4083.
10. Fisher C, Schofield JB. S-100 protein positive synovial sarcoma. Histopathology. 1991;19:375-377.
11. Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002:427.
12. Flucke U, Palmedo G, Blankenhorn N, et al. EWSR1 gene rearrangement occurs in a subset of cutaneous myoepithelial tumors: a study of 18 cases. Mod Pathol. 2011;24:1444-1450.
13. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1-30. (Pubitemid 38031617)
14. Goh YW, Spagnolo DV, Platten M, et al. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation. Histopathology. 2001;39:514-524. (Pubitemid 34225173)
15. Hajdu SI, Shiu MH, Fortner JG. Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer. 1977;39:1201-1217. (Pubitemid 8081195)
16. Horvai AE, Kramer MJ, O'Donnell R. Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study. Arch Pathol Lab Med. 2006;130:792-798. (Pubitemid 43886997)
17. Iliszko M, Rys J, Wozniak A, et al. Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. Cancer Genet Cytogenet. 2009; 189:118-121.
18. Kilpatrick SE, Doyon J, Choong PF, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 1996;77:1450-1458. (Pubitemid 26105379)
19. Krane JF, Bertoni F, Fletcher CD. Myxoid synovial sarcoma: an underappreciated morphologic subset. Mod Pathol. 1999;12:456-462. (Pubitemid 29230605)
20. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multiinstitutional retrospective study of 243 patients. Cancer Res. 2002; 62:135-140. (Pubitemid 34073997)
21. Meis-Kindblom JM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch. 2001;439:141-151. (Pubitemid 32758907)
22. Nishio J, Iwasaki H, Ishiguro M, et al. Synovial sarcoma with a secondary chromosome change der(22)t(17;22)(q12;q12). Cancer Genet Cytogenet. 2002;137:23-28.
23. Okamoto S, Hisaoka M, Ishida T, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol. 2001;32:1116-1124. (Pubitemid 33015673)
24. Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer. 2002;99: 560-567. (Pubitemid 34461609)
25. Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res. 2007;13:7322-7328.
26. Saito T, Nagai M, Ladanyi M. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. Cancer Res. 2006;66:6919-6927. (Pubitemid 44197666)
27. Sandberg AA. Genetics of chondrosarcoma and related tumors. Curr Opin Oncol. 2004;16:342-354. (Pubitemid 38870040)
28. Skytting B, Nilsson G, Brodin B, et al. A novel fusion gene, SYTSSX4, in synovial sarcoma. J Natl Cancer Inst. 1999;91:974-975. (Pubitemid 29275883)
29. Storlazzi CT, Mertens F, Mandahl N, et al. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes Chromosomes Cancer. 2003;37:195-200. (Pubitemid 36529787)
30. Sun B, Sun Y, Wang J, et al. The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RTPCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases. Cancer Sci. 2008;99:1355-1361. (Pubitemid 351761724)
31. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. St Louis: Mosby; 2008.
32. Xie Y, Skytting B, Nilsson G, et al. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res. 2002;62:3861-3867. (Pubitemid 34728873)
33. Xie Y, Skytting B, Nilsson G, et al. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery. Oncogene. 2002;21:5791-5796. (Pubitemid 35333013)